High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$6.0M
$5,963,032
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
BIOA
S
BioAge Labs, Inc.
RUBIN PAUL D
• Officer • Chief Medical Officer
10b5-1 Sell
2026-03-02
$150,890
|
||||||
| BIOA |
BioAge Labs, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-03-02 | $150,890 | S | Form 4 |
|
BIOA
S
BioAge Labs, Inc.
RUBIN PAUL D
• Officer • Chief Medical Officer
10b5-1 Sell
2026-02-02
$139,369
|
||||||
| BIOA |
BioAge Labs, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-02-02 | $139,369 | S | Form 4 |
| BIOA |
BioAge Labs, Inc.
|
CEO
10b5-1 SellΔOwn -19.3%
|
2026-01-13 | $4,223,036Large | S | Form 4 |
| BIOA |
BioAge Labs, Inc.
|
CFO
10b5-1 Sell
|
2026-01-13 | $531,828x4 | S | Form 4 |
|
BIOA
S
BioAge Labs, Inc.
RUBIN PAUL D
• Officer • Chief Medical Officer
10b5-1 Sell
2025-12-09
$216,000
|
||||||
| BIOA |
BioAge Labs, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-12-09 | $216,000 | S | Form 4 |
|
BIOA
S
BioAge Labs, Inc.
RUBIN PAUL D
• Officer • Chief Medical Officer
10b5-1 Sell
2025-12-04
$701,909
|
||||||
| BIOA |
BioAge Labs, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-12-04 | $701,909 | S | Form 4 |